Clinical Trials Sponsored by Alicia Gerke

Total 315 results

Alicia Gerke
Pulmonary Fibrosis Foundation

Terminated

Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis | Pulmonary Fibrosis

United States
Henning Gerke

Completed

SharkCore Versus Acquire FNB

EUS Guided Biopsy

United States
Fundacin Biomedica Galicia Sur
University of Vigo; Galician South Health Research Institute

Not yet recruiting

Differential Diagnosis of Persistent COVID-19 by Artificial Intelligence (DICOPERIA)

COVID-19 | Fatigue | Cognitive Dysfunction | COVID-19 Recurrent | SARS CoV 2 Infection | Distress Respiratory Syndrome

Spain
Fundacin Biomedica Galicia Sur
University of Vigo; Galician South Health Research Institute

Not yet recruiting

Efficacy of a Physical and Respiratory Rehabilitation Program for Patients With Persistent COVID-19 (SARS-CoV-2). (COPERIA-REHAB)

Fatigue | Cognitive Dysfunction | SARS-CoV-2 Infection | COVID-19 Recurrent

Spain
Alicia Koontz

Completed

Effect of Vibration Exercise on Upper Limb Strength, Function, and Pain

Spinal Cord Injuries

United States
Alicia Koontz

Completed

Functional Electrical Stimulation Use in Trans-tibial Amputations

Traumatic Amputation of Lower Extremity

United States
University of Deusto
Fundación Alicia Koplowitz

Completed

Building Resilience in Cyberbullying Victims (Resilience)

Depression | Social Anxiety | Eating Disorders | Cyberbullying | Non Suicidal Self Injury

Spain
Adocia

Completed

A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Germany
Adocia

Completed

A Trial to Compare Post Prandial Blood Glucose Control of BioChaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

Germany
Adocia

Completed

A Clinical Trial Investigating the Intra-subject Variability of Pharmacokinetics and Glucodynamics of BioChaperone Insulin Lispro U-100 Product and U-200 Product in Healthy Volunteers

Healthy

Germany
Adocia

Completed

A Trial to Compare BioChaperone Insulin Lispro Formulations With US Approved Humalog® and With EU Approved Humalog® in Patients With Type 1 Diabetes Mellitus

Type 1 Diabetes

Germany
Adocia

Completed

A Trial to Investigate the Dose-linearity of BioChaperone® Combo 75/25 and the Safety at Three Different Doses in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

Germany
Adocia

Completed

A Double-blinded, Randomised, Two -Period Crossover Euglycemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Insulin Lispro and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes

Diabetes Mellitus Type 1

Germany
Adocia

Completed

A Trial to Assess the Efficacy and Safety of BioChaperone Combo and Humalog Mix 25 in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Germany
Adocia

Completed

A Double-blinded, Randomised, Three-period Crossover Euglycaemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Human Insulin, Human Insulin (Huminsulin® Normal) and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes

Diabetes Mellitus Type 1

Germany
Adocia

Completed

A Double-blinded, Randomised, Four-period Crossover Euglycemic Clamp Trial Investigating the Dose-response and Dose-exposure Relationship of BioChaperone Insulin Lispro in Three Different Doses in Subjects With Type 1 Diabetes

Diabetes Mellitus Type 1

Germany
Adocia

Completed

A Trial to Assess the Efficacy and Safety of M1 Pram P037 Prandial Insulin in Subjects With Type 1 Diabetes (T1DM)

Type 1 Diabetes Mellitus

Germany
Adocia

Completed

A Trial to Assess Safety and Efficacy of ADO09 Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Germany
Adocia

Completed

A Trial to Investigate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BioChaperone® Pramlintide Insulin in Patients With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Germany
Adocia

Completed

A Trial to Investigate the Safety and the Pharmacokinetic, Pharmacodynamic Characteristics of Two BioChaperone® Glucagon Formulations Compared to Marketed GlucaGen® in Subjects With T1DM

Type 1 Diabetes Mellitus

Germany
Adocia

Completed

A Trial to Evaluate the Pharmacokinetic and Pharmacodynamic Properties of BioChaperone® Insulin Lispro, Fiasp® and NovoRapid® Delivered by an Insulin Pump

Type1 Diabetes Mellitus

Germany
Adocia

Completed

Blood Glucose Control With BioChaperone Insulin Lispro Compared to Insulin Lispro (Humalog®) After Ingestion of a Standardized Meal

Diabetes Mellitus Type 1

Germany
Adocia

Completed

A Trial to Investigate Post Prandial Blood Glucose Control With Fast-acting Human Insulin HinsBet® Compared to Insulin Lispro (Humalog®) and Regular Human Insulin (Huminsulin® Normal) After Ingestion of a Standardized Meal in Subjects With T1DM

Type 1 Diabetes Mellitus

Germany
Adocia

Completed

A Trial to Compare the Pharmacodynamic and Pharmacokinetic Properties of Biochaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

Germany
Adocia

Completed

Postprandial Blood Glucose Control With BioChaperone® Combo and Insulin Lispro (Humalog®) Mix 25 in People With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Germany
Avidia

Unknown

Phase 1 Study of Safety and Biological Effects of C326, an Inhibitor of IL-6, in Crohn's Disease

Crohn's Disease

Australia
Fundacin Biomedica Galicia Sur

Not yet recruiting

Effect of the Nutraceutical "MICODIGEST 2.0" on the Complications After Surgery for Colorectal Cancer

Colorectal Cancer | Surgery--Complications
Fundacin Biomedica Galicia Sur

Completed

Efficacy of the Social Cognition Rehabilitation Program E-motional Training in the Treatment of Patients With Substance-related Disorders

Social Behavior

Spain
Fundacin Biomedica Galicia Sur

Recruiting

Single Antiplatelet Treatment With Ticagrelor or Aspirin After Transcatheter Aortic Valve Implantation (REAC-TAVI2)

Aortic Valve Stenosis | Severe Aortic Valve Stenosis | Transcatheter Aortic Valve Implantation (TAVI) | Transcatheter Aortic Valve Replacement (TAVR)

Spain
Fundacin Biomedica Galicia Sur

Recruiting

Clinical Validation of PolyDeep: an Artificial Intelligence-based Computer-aided Polyp Detection (CADe) and Characterization (CADx) System. Polydeep Advance 3

Colorectal Cancer

Spain
Fundacin Biomedica Galicia Sur

Recruiting

Polyprev: Study to Compare Fecal Immunochemical Test With Endoscopic Surveillance After Advanced Adenoma Resection in Fecal Immunochemical Test Colorectal Cancer Screening Programs.

Colorectal Cancer

Spain
Fundacin Biomedica Galicia Sur

Enrolling by invitation

"Youth Aware of Mental Health" in Galicia (YAM)

Suicidal Ideation | Suicide, Attempted | Depressive Symptoms | Cyberbullying | Bullying | Help-Seeking Behavior | Suicide Awareness

Spain
Fundacin Biomedica Galicia Sur

Completed

Clinical Validation of PolyDeep: an Artificial Intelligence-based Computer-aided Polyp Detection (CADe) and Characterization (CADx) System. Polydeep Advance 2.

Colorectal Cancer

Spain
Fundacin Biomedica Galicia Sur

Completed

Clinical Validation of Polydeep: an Artificial Intelligence-based Computer-aided Polyp Detection (CADe) and Characterization (CADx) System

Colorectal Cancer

Spain
Fundacin Biomedica Galicia Sur

Unknown

CoreValve™ Evolut R™ 34 mm System Registry (CoreValve34) (TAVI34mm)

Aortic Valve Stenosis | Transcatheter Aortic Valve Implantation

Spain
Elicio Therapeutics

Recruiting

A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors (AMPLIFY-7P)

Colorectal Cancer | Pancreatic Ductal Adenocarcinoma | KRAS G12D | KRAS G12R | NRAS G12D | NRAS G12R | KRAS G12V | KRAS G12C | KRAS G12A | KRAS G12S | KRAS G13D | NRAS G12V | NRAS G12C | NRAS G12S

United States
Alydia Health

Completed

Feasibility Clinical Investigation Using the InPress Device for the Treatment of Postpartum Hemorrhage

Post Partum Hemorrhage

Indonesia
Alydia Health

Completed

RUBY Post-Market Registry on the Jada® System (RUBY)

Postpartum Hemorrhage

United States
Alaxia SAS

Terminated

Dose Escalation Study of ALX-009 in Healthy Men and Cystic Fibrosis (CF) and Non-CF Bronchiectasis Patients

Bronchiectasis | Cystic Fibrosis

France
Alaxia SAS

Recruiting

Dose Finding Study of STR-324

Pain, Acute

Netherlands
Elicio Therapeutics

Active, not recruiting

A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors (AMPLIFY-201)

Colorectal Cancer | Ovarian Cancer | Cholangiocarcinoma | Bile Duct Cancer | Non-small Cell Lung Cancer | Pancreatic Ductal Adenocarcinoma | Minimal Residual Disease | Gallbladder Carcinoma | KRAS G12D | KRAS G12R | NRAS G12D | NRAS G12R

United States
Alydia Health

Completed

Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage (PEARLE)

Postpartum Hemorrhage

United States
Alcis

Not yet recruiting

EPC Performance Investigation for StereoElectroEncephaloGraphy (EPISEEG)

Epilepsy
Alcis

Completed

The Objective of This Multicentre Study is to Collect Operative Data on the Related Clinical Functional Outcomes and Complications and of Market Approved Alcis Electrophysiology Catheters to Demonstrate Safety and Performance of These Devices in a Real-world Setting

Cardiac Arrhythmia

France
Fundacin Biomedica Galicia Sur
Centro de Investigación Biomédica en Red de Salud Mental; Galician South Health...

Not yet recruiting

Randomised Clinical Trial to Evaluate the Efficacy of an Online Cognitive Rehabilitation Programme (COPERIA-COG) for Patients With Persistent COVID-19 (COPERIA-COG)

COVID-19 | SARS CoV 2 Infection | Psychological | Neuro-Degenerative Disease

Spain
Kaligia Biosciences, LLC

Unknown

A Human Clinical Study to Collect Calibration and Performance Data for the RBA-1 and KBS-1

Calibration and Validation of Analyte Testing System

United States
Acacia Pharma Ltd

Completed

US Phase III Study of APD421 in PONV

PONV

United States
Acacia Pharma Ltd

Completed

Study of APD421 as PONV Treatment (Prior Prophylaxis)

Postoperative Nausea and Vomiting

United States, Germany, France
Acacia Pharma Ltd

Completed

Thorough QT Study of Intravenous Amisulpride

Healthy
Acacia Pharma Ltd

Completed

Study of APD421 With and Without Ondansetron

Postoperative Nausea and Vomiting

United Kingdom

3

Subscribe